MiPod Nuclear is in licensing deal for isotope technology

10/20/2010 | Yahoo!

MiPod Nuclear has entered a licensing deal that gives Vector Trading exclusive rights to its patent-pending technology for the production of Mo-99 medical isotope. The agreement covers the use of the technology, which will employ depleted uranium in its procedure, in Australia and New Zealand.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA